BENJAMIN ROBERTS: Open Payments
NPI 1922653039 · SPANISH FORK, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,297 in 75 payments from 20 companies in 2025. Trend: 2023 $1,482 · 2024 $1,790 · 2025 $1,297
Food & beverage: $1,297
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $375 |
| Otsuka America Pharmaceutical, Inc. | 12 | $170 |
| Indivior Inc. | 7 | $144 |
| Alkermes, Inc. | 4 | $79 |
| Lilly USA, LLC | 4 | $71 |
| Novo Nordisk Inc | 4 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $44 |
| PFIZER INC. | 3 | $43 |
| Astellas Pharma US Inc | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
Products named: VRAYLAR, REXULTI, SUBLOCADE, ARISTADA, MOUNJARO, QULIPTA, Wegovy, CAPLYTA.
Industry payments across UT — which companies pay providers there.
